Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and gynecological acceptability evaluation of investigational product D26.255.955 for vaginal dryness
RBR-422ssnPhase 3Not yet recruiting
- Sponsor
- Medcin Instituto da Pele
- Start
- Nov 2018
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in vaginal dryness, sponsored by Medcin Instituto da Pele. Primary endpoints: Gynecological acceptability and Perceived efficacy. Planned start Nov 2018; status: not yet recruiting.
02
Conditions
vaginal dryness
Beyond the preview
Go deeper on RBR-422ssn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-422ssn.